FDA clears ProTom's Radiance proton therapy system

2016 09 02 09 36 05 93 Fda Logo V2 400

The U.S. Food and Drug Administration (FDA) has cleared proton therapy developer ProTom International's Radiance 330 single-room proton therapy system.

The system, installed at Massachusetts General Hospital in Boston, can be sited within a vault space of 20 x 30 ft and requires 40% less radiation shielding than conventional proton therapy systems, according to the firm.

Page 1 of 461
Next Page